Brief: Truscreen Group Signs MoU With Hangzhou Dalton Bioscience
Feb 27 (Reuters) - Truscreen Group Ltd TRU.NZ: TRUSCREEN SIGNS MOU WITH HANGZHOU DALTON BIOSCIENCE TO EXPAND ITS HPV PRODUCT OFFERINGS Further company coverage: TRU.NZ ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Truscreen
See all newsBrief: Truscreen Group Says Tony Ho To Resume Role As Independent Non-Executive Chairman
New Zealand's TruScreen tumbles on discounted placement
Brief: Truscreen Group Says NZ Regco Has Approved A Trading Halt
Brief: Truscreen Announces Opening Of NZ$2.9 Million Capital Raise
Brief: Truscreen Group Sees FY26 Unaudited Loss